Morgan Stanley Maintains Equal-Weight on Erasca, Raises Price Target to $21

Benzinga Newsdesk www.benzinga.com Positive 52.3%

Neg 0% Neu 0% Pos 52.3%

Morgan Stanley analyst Sean Laaman maintains Erasca (NASDAQ:ERAS) with a Equal-Weight and raises the price target from $12 to $21.